Cannabis-Related Psychosis Has a More Chronic Course Than Expected for 'Substance-Induced' Diagnoses
Cannabis-associated psychosis showed a more chronic trajectory than cocaine-induced psychosis, with better initial prognosis than negative-screen patients but more recurrence than expected for a truly substance-induced condition.
Quick Facts
What This Study Found
Cannabis alone at first psychosis presentation showed improved prognosis compared to negative drug screens but more chronic course than expected for substance-induced psychosis; cocaine showed the clearest substance-induced pattern with quick remission and low recurrence.
Key Numbers
1,379 patients followed 5 years; cannabis alone and cannabis+stimulants showed improved prognosis vs. negative screens but more chronic course than cocaine-alone (which fit substance-induced pattern).
How They Did This
5-year retrospective longitudinal study of 1,379 patients following first psychosis presentation, grouped by urine drug screen results, comparing encounter duration, recurrence, healthcare utilization, and drug-screen-negative recurrence.
Why This Research Matters
The assumption that cannabis-related psychosis is purely 'substance-induced' and will resolve with abstinence may be wrong — many patients follow a more chronic course suggesting cannabis may trigger lasting psychotic vulnerability.
The Bigger Picture
This challenges the binary classification of psychosis as either 'primary' or 'substance-induced' — cannabis-related psychosis may represent a distinct entity requiring different treatment approaches than either category assumes.
What This Study Doesn't Tell Us
Retrospective design; urine drug screens capture recent use only; cannot determine causation; single regional medical center; loss to follow-up in 5-year window.
Questions This Raises
- ?Should cannabis-related psychosis be treated differently from primary psychosis?
- ?Does protracted abstinence from cannabis eventually resolve the chronic psychotic trajectory?
Trust & Context
- Key Stat:
- Evidence Grade:
- Large retrospective cohort with 5-year follow-up and objective drug screening, though limited by single-site design and retrospective methodology.
- Study Age:
- Published in 2026, using data from 2013 onward, contributing to the evolving understanding of cannabis-psychosis relationships.
- Original Title:
- Predicting the prognosis of primary and substance-associated psychoses using urine drug screens: A 5-year retrospective longitudinal study using medical records.
- Published In:
- Schizophrenia research, 290, 57-64 (2026)
- Authors:
- Aschenbrenner, Erich J, Voluse, Andrew C(2)
- Database ID:
- RTHC-08091
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Is cannabis-related psychosis permanent?
This study found cannabis-related psychosis followed a more chronic course than typical 'substance-induced' psychosis, but better initial prognosis than primary psychosis — suggesting it occupies a middle ground.
How does cannabis psychosis compare to cocaine psychosis?
Cocaine-related psychosis showed the expected pattern of quick remission and rare recurrence. Cannabis-related psychosis was more persistent, suggesting different underlying mechanisms.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- thc-and-adderall-stimulants-cannabis-brain
- thc-and-caffeine-most-common-drug-combo
Cite This Study
https://rethinkthc.com/research/RTHC-08091APA
Aschenbrenner, Erich J; Voluse, Andrew C. (2026). Predicting the prognosis of primary and substance-associated psychoses using urine drug screens: A 5-year retrospective longitudinal study using medical records.. Schizophrenia research, 290, 57-64. https://doi.org/10.1016/j.schres.2026.01.023
MLA
Aschenbrenner, Erich J, et al. "Predicting the prognosis of primary and substance-associated psychoses using urine drug screens: A 5-year retrospective longitudinal study using medical records.." Schizophrenia research, 2026. https://doi.org/10.1016/j.schres.2026.01.023
RethinkTHC
RethinkTHC Research Database. "Predicting the prognosis of primary and substance-associated..." RTHC-08091. Retrieved from https://rethinkthc.com/research/aschenbrenner-2026-predicting-the-prognosis-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.